Assessing risk factors as potential screening tests: A simple assessment tool

Archives of Internal Medicine

Volumn 171, Issue 4, 2011, Pages 286-291

  Wald, Nicholas J ^a   Morris, Joan K ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; DNA POLYMORPHISM; FALSE POSITIVE RESULT; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

CARDIOVASCULAR DISEASES; HUMANS; MASS SCREENING; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS;

EID: 79251545943     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.378     Document Type: Article

References (10)

1. Wald NJ, Hackshaw AK, Frost CD. When can a risk factor be used as a worthwhile screening test? BMJ. 1999;319(7224):1562-1565.
2. Boekholdt SM, Kastelein JJP. C-reactive protein and cardiovascular risk: more fuel to the fire. Lancet. 2010;375(9709):95-96.
3. Ng PC, Murray SS, Levy S, Venter JC. An agenda for personalized medicine. Nature. 2009;461(7265):724-726.
4. Wald NJ, Law M, Watt HC, et al. Apolipoproteins and ischaemic heart disease: implications for screening. Lancet. 1994;343(8889):75-79. (Pubitemid 24019347)
5. Wald NJ, Morris JK, Rish S. The efficacy of combining several risk factors as a screening test. J Med Screen. 2005;12(4):197-201. (Pubitemid 43843295)
6. Zethelius B, Berglund L, Sundström J, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.N Engl J Med. 2008;358(20):2107-2116. (Pubitemid 351679597)
7. Kaptoge S, Di Angelantonio E, Lowe G, et al; Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132-140.
8. Vliegenthart R, Oudkerk M, Hofman A, et al. Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation. 2005;112(4):572-577. (Pubitemid 41060798)
9. Selvin E, Steffes MW, Zhu H, et al. Glycated haemoglobin, diabetes, and cardiovascular risk in non-diabetic adults. N Engl J Med. 2010;362(9):800-811.
10. Collins GS, Altman DG. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. BMJ. 2009;339:b2584.